A Study Of Hba1c Estimation In 1st Trimester And Its Relationship With The Risk For Gestational Diabetes Mellitus
Main Article Content
Abstract
Gestational diabetes, often referred to as GDM, is a prevalent pregnancy complication that is linked to detrimental consequences for both the mother and the baby. Specifically, mothers with GDM face an elevated risk of developing type 2 diabetes and cardiovascular diseases later in life, while their offspring are at an increased risk of macrosomia and obesity. Nearly 90% of pregnant women in Diabetes Mellitus are diagnosed with GDM. The prevalence of GDM varies in different regions based on factors such as ethnicity, race, and lifestyle. In India, the prevalence of GDM ranges from 3.8% to 20%. The use of glycosylated haemoglobin (HbA1c) is primarily intended for diagnosing and managing type 2 diabetes mellitus. Compared to FBS and PP tests, HbA1c measures the average glucose concentration from the previous two to three months. This test does not require fasting and has lower intra-individual variability, making it a more suitable option for patients.